The Association of the British Pharmaceutical Industry (ABPI) is saddened to learn of the death of its former ABPI Medical Director, Dr Richard Tiner.
Having previously worked as a GP in Taunton for 16 years, Dr Tiner joined the UK trade association as Medical Director in 1996 and served until becoming the President of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians in 2009.
During his lifetime, Dr Richard Tiner worked as a National Research Ethics Advisor, the President of the Pharmaceutical Medicines and Research Section of the Royal Society of Medicine and sat on a number of important committees and boards for health in the UK including the National Cancer Research Institute Board, the Medical Advisory Board of the General Practice Research Database (GPRD) and the UK Clinical Research Collaboration Board.
### ENDS ###
ABPI Press OfficeEmail: firstname.lastname@example.org
9am to 5pm Monday to Friday: +44 (0) 20 7747 7147 or +44 (0) 20 7747 14415pm to 9am and weekends: +44 (0) 20 7747 1445
About the ABPI
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.
Globally our industry is researching and developing more than 7,000 new medicines.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK.